Summit Therapeutics Inc. (SMMT) Net margin 2017–2022
Summit Therapeutics Inc. (SMMT) net profit margin by fiscal year — reported net income divided by reported revenue.
-11174.8%FY2022 · since FY2017: -163.6% → -11174.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -11174.8% | -6276.9 pp |
| FY2021 | -4897.8% | +1229.7 pp |
| FY2020 | -6127.6% | — |
| FY2018 | 19.0% | +182.7 pp |
| FY2017 | -163.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice